Biomaterials.info

powered by FreeFind

US Food and Drug Administration (FDA) - Inactive Ingredients
FDA Inactive Ingredients - Updated May 2006

What is the purpose of the Inactive Ingredients Database?

The Inactive Ingredients Database provides information on inactive ingredients present in FDA-approved drug products. This information can be used by industry as an aid in developing drug products. For new drug development purposes, once an inactive ingredient has appeared in an approved drug product for a particular route of administration, the inactive ingredient is not considered new and may require a less extensive review the next time it is included in a new drug product. For example, if a particular inactive ingredient has been approved in a certain dosage form at a certain potency, a sponsor could consider it safe for use in a similar manner for a similar type of product. 		FDA Devices
FDA Inactive Ingredients
FDA Inactive Ingredients
FDA Inactive Ingredients


First Page Previous Page Next Page Last Page
Inactive Ingredient Route / Dosage Form
EDETIC ACID ORAL; TABLET, FILM COATED
EDETIC ACID RECTAL; SUPPOSITORY
EDETIC ACID TOPICAL; LOTION
EDETIC ACID TOPICAL; SHAMPOO
EDETIC ACID TOPICAL; SOLUTION
EGG YOLK PHOSPHATIDES INTRAVENOUS; EMULSION, INJECTION
EGG YOLK PHOSPHATIDES INTRAVENOUS; INJECTION
EGG YOLK PHOSPHATIDES IV(INFUSION); INJECTION
EIDERDOWN SOAP ORAL; TABLET, REPEAT ACTION
EIDERDOWN SOAP ORAL; TABLET, SUSTAINED ACTION
ENTSUFON TOPICAL; EMULSION
ENTSUFON TOPICAL; SPONGE
ENTSUFON SODIUM TOPICAL; EMULSION
ENTSUFON SODIUM TOPICAL; SPONGE
EPILACTOSE ORAL; SOLUTION
EPILACTOSE RECTAL; SOLUTION
ERYTHORBIC ACID ORAL; CONCENTRATE
ERYTHORBIC ACID ORAL; TABLET
ESSENCE BOUQUET 9200 TOPICAL; LOTION
ESSENCE FRITZBRO ORANGE ORAL; SUSPENSION
ESSENCE LEMON ORAL; SYRUP
ESSENCE ORANGE ORAL; SYRUP
ETHANOLAMINE HYDROCHLORIDE INTRAVENOUS; INJECTION
ETHER ORAL; CAPSULE
ETHER SUBLINGUAL; AEROSOL
ETHYL ACETATE INTRAMUSCULAR; INJECTION, MICROSPHERES
ETHYL ACETATE ORAL; CAPSULE, SUSTAINED ACTION
ETHYL ACETATE ORAL; SUSPENSION
ETHYL ACETATE ORAL; TABLET
ETHYL ACETATE ORAL; TABLET, DELAYED RELEASE
ETHYL ACETATE ORAL; TABLET, SUSTAINED ACTION
ETHYL ACETATE TOPICAL; SOLUTION
ETHYL ACETATE TRANSDERMAL; FILM, CONTROLLED RELEASE
ETHYL HEXANEDIOL TOPICAL; SOLUTION
ETHYL MALTOL ORAL; SOLUTION
ETHYL MALTOL ORAL; SOLUTION, ELIXIR
ETHYL MALTOL ORAL; SYRUP
ETHYL OLEATE TRANSDERMAL; FILM, CONTROLLED RELEASE
ETHYL VANILLIN ORAL; CAPSULE
ETHYL VANILLIN ORAL; CAPSULE, COATED, SOFT GELATIN
ETHYL VANILLIN ORAL; CAPSULE, SOFT GELATIN
ETHYL VANILLIN ORAL; CAPSULE, SUSTAINED ACTION
ETHYL VANILLIN ORAL; SUSPENSION
ETHYL VANILLIN ORAL; SYRUP
ETHYL VANILLIN ORAL; TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE
ETHYLCELLULOSE ORAL; CAPSULE
ETHYLCELLULOSE ORAL; CAPSULE, EXTENDED RELEASE
ETHYLCELLULOSE ORAL; CAPSULE, SUSTAINED ACTION
ETHYLCELLULOSE ORAL; CAPSULE, SUSTAINED ACTION, HARD GELATIN
ETHYLCELLULOSE ORAL; GRANULE, FOR SUSPENSION
ETHYLCELLULOSE ORAL; GRANULE, FOR SUSPENSION, EXTENDED RELEASE
ETHYLCELLULOSE ORAL; POWDER, FOR SUSPENSION
ETHYLCELLULOSE ORAL; SUSPENSION, SUSTAINED ACTION
ETHYLCELLULOSE ORAL; TABLET
ETHYLCELLULOSE ORAL; TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE
ETHYLCELLULOSE ORAL; TABLET, COATED
ETHYLCELLULOSE ORAL; TABLET, DELAYED ACTION, ENTERIC COATED
ETHYLCELLULOSE ORAL; TABLET, EXTENDED RELEASE
ETHYLCELLULOSE ORAL; TABLET, FILM COATED
ETHYLCELLULOSE ORAL; TABLET, ORALLY DISINTEGRATING
ETHYLCELLULOSE ORAL; TABLET, SUSTAINED ACTION
ETHYLCELLULOSE ORAL; TABLET, SUSTAINED ACTION, COATED
ETHYLCELLULOSE ORAL; TABLET, SUSTAINED ACTION, FILM COATED
ETHYLCELLULOSE ORAL-28; TABLET
ETHYLCELLULOSE TOPICAL; PATCH
ETHYLCELLULOSE TRANSDERMAL; FILM, CONTROLLED RELEASE
ETHYLCELLULOSE VAGINAL; TABLET
ETHYLENE ORAL; CAPSULE
ETHYLENE GLYCOL TOPICAL; SHAMPOO, SUSPENSION
ETHYLENE GLYCOL MONOETHYL ETHER ORAL; CAPSULE
ETHYLENE VINYL ACETATE COPOLYMER INTRAUTERINE; SUPPOSITORY, INSERT, CONTROLLED RELEASE
ETHYLENE VINYL ACETATE COPOLYMER OPHTHALMIC; SUPPOSITORY, INSERT, CONTROLLED RELEASE
ETHYLENE VINYL ACETATE COPOLYMER PERIODONTAL; FILM, CONTROLLED RELEASE
ETHYLENE VINYL ACETATE COPOLYMER TRANSDERMAL; FILM, CONTROLLED RELEASE
ETHYLENE VINYLACETATE COPOLYMER, 28% VINYLACETATE VAGINAL; SPONGE
ETHYLENE VINYLACETATE COPOLYMER, 9% VINYLACETATE VAGINAL; SPONGE
ETHYLENEDIAMINE DIHYDROCHLORIDE TOPICAL; EMULSION, CREAM
ETHYLENE-PROPYLENE COPOLYMER TRANSDERMAL; FILM, CONTROLLED RELEASE
ETHYLPARABEN ORAL; POWDER, FOR SOLUTION
ETHYLPARABEN TOPICAL; EMULSION, CREAM
ETHYLPARABEN SODIUM ORAL; CAPSULE, SOFT GELATIN
EUCALYPTOL DENTAL; SOLUTION
EUCALYPTUS OIL ORAL; SYRUP
EUDRAGIT E 100 ORAL; CAPSULE, SUSTAINED ACTION
EUDRAGIT E 100 ORAL; TABLET
EUDRAGIT E 100 ORAL; TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE
EUDRAGIT E 100 ORAL; TABLET, COATED
EUDRAGIT E 100 ORAL; TABLET, FILM COATED
EUDRAGIT E 100 ORAL; TABLET, ORALLY DISINTEGRATING
EUDRAGIT E 100 ORAL; TABLET, SUSTAINED ACTION
EUDRAGIT E 100 TRANSDERMAL; FILM, CONTROLLED RELEASE
EUDRAGIT L 100 ORAL; CAPSULE, ENTERIC COATED PELLETS
EUDRAGIT L 100 ORAL; CAPSULE, SUSTAINED ACTION
EUDRAGIT L 100 ORAL; TABLET, CONTROLLED RELEASE
EUDRAGIT L 100 - 55 ORAL; TABLET, DELAYED ACTION
EUDRAGIT L 100 - 55 ORAL; TABLET, DELAYED ACTION, ENTERIC COATED
EUDRAGIT L 30 D ORAL; CAPSULE, ENTERIC COATED PELLETS
EUDRAGIT L 30 D ORAL; CAPSULE, SUSTAINED ACTION
EUDRAGIT L 30 D ORAL; TABLET, DELAYED ACTION, ENTERIC COATED
EUDRAGIT L 30 D ORAL; TABLET, ENTERIC COATED PARTICLES

First Page Previous Page Next Page Last Page




Last Modified: 29 April 2006
http://www.biomaterials.info
Sitemap
Link | Link | Link | Link | Link | Link | Link | Link